The naturally‐derived alkaloids as a potential treatment for COVID‐19: A sco** review

BL Gonzalez, NC de Oliveira, MR Ritter… - Phytotherapy …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS‐CoV‐2), which has a high mortality rate and …

[HTML][HTML] Efficacy of liraglutide in non-diabetic obese adults: a systematic review and meta-analysis of randomized controlled trials

JJ Barboza, MR Huaman, B Melgar… - Journal of Clinical …, 2022 - mdpi.com
JCM | Free Full-Text | Efficacy of Liraglutide in Non-Diabetic Obese Adults: A Systematic
Review and Meta-Analysis of Randomized Controlled Trials Next Article in Journal Health …

[HTML][HTML] Novel Impact of Colchicine on Interleukin-10 Expression in Acute Myocardial Infarction: An Integrative Approach

SD Handari, MS Rohman, D Sargowo… - Journal of Clinical …, 2024 - mdpi.com
Background: Inflammation plays a critical role in myocardial infarction as a critical process in
the development of heart failure, involving the development of cardiac fibrosis. Colchicine is …

The role of colchicine in different clinical phenotypes of Behcet disease

Z Wang, X Zu, S **ong, R Mao, Y Qiu, B Chen… - Clinical …, 2023 - Elsevier
Purpose Behcet disease (BD) is a multisystemic disorder characterized by variable clinical
manifestations that affect nearly all systems and organs. Colchicine, an alkaloid plant …

Colchicine–new horizons for an ancient drug. Review based on the highest hierarchy of evidence

A Schattner - European Journal of Internal Medicine, 2022 - Elsevier
Colchicine is an old, inexpensive, and relatively safe anti-inflammatory drug traditionally
used in gout and over the last 50 years in familial Mediterranean fever. A search of all high …

Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: a systematic review and meta-analysis

Y Zhou, Y Liu, R Zeng, W Qiu, Y Zhao… - Frontiers in …, 2023 - frontiersin.org
Background Current evidence on the efficacy and safety of colchicine after acute myocardial
infarction (AMI) remains controversial. This study aims to clarify early low-dose long-term …

[HTML][HTML] Low-dose colchicine for stroke prevention: a systematic overview of systematic reviews and meta-analyses

G Noll, WV Borelli, GP Mantovani, SCO Martins… - Journal of Stroke and …, 2024 - Elsevier
Background Stroke incidence remains a significant concern despite optimized prevention
strategies. Colchicine shows potential for improving stroke prevention globally. Aims To …

Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous …

S Khiali, M Taban-Sadeghi, P Sarbakhsh… - Trials, 2023 - Springer
Background Patients with acute myocardial infarction are at greater risk for chronic heart
failure and mortality. Currently, there is limited evidence supporting the beneficial effects of …

Concizumab en pacientes con Hemofilia A/B: una revisión sistemática

A Valle-Chafloque, K Uchofén-Mondragón… - Revista del Cuerpo …, 2022 - cmhnaaa.org.pe
Objetivo: Evaluamos sistemáticamente la eficacia de Concizumab en pacientes con
Hemofilia A/B. Material y Métodos: Se buscaron en cinco bases de datos hasta mayo de …

Effect of Colchicine on Neutrophil to Lymphocyte Ratio and Cardiac Function in Non-Diabetic Patients Post STEMI Using Speckle Tracking Imaging

SM Elsaughier, HM Mansour, OO Ahmed… - The Egyptian Journal of … - ejhm.journals.ekb.eg
Background: Acute myocardial ischemia is accompanied by myocardial necrosis and
endogenous inflammation, resulting in myocardial injury, ventricular dilation, and …